FMP
Axcella Health Inc.
AXLA
NASDAQ
Inactive Equity
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
4.58 USD
4.1791 (91.25%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Craig R. Jalbert CIRA
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Mas...
CIK
0001633070
ISIN
US05454B2043
CUSIP
05454B105
Address
840 Memorial Drive
Phone
857 320 2200
Country
US
Employee
11
IPO Date
May 9, 2019
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
AXLA Financial Summary
CIK
0001633070
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
05454B105
ISIN
US05454B2043
Country
US
Price
4.58
Beta
0.57
Volume Avg.
0
Market Cap
0
Shares
-
52-Week
-
DCF
0.28
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.25
P/B
-
Website
https://www.axcellahealth.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AXLA News
It looks like there's no news available.
